摘要:
Systems and method of compensating for transmission impairment are disclosed. One such method comprises: receiving an optical signal which has been distorted in the physical domain by an optical transmission channel; and propagating the distorted optical signal backward in the electronic domain in a corresponding virtual optical transmission channel.
摘要:
Systems and methods are disclosed for compensating for impairments caused by a semiconductor optical amplifier (SOA). One such method comprises receiving an optical signal which has been distorted in the physical domain by an SOA, and propagating the distorted optical signal backward in the electronic domain in a corresponding virtual SOA.
摘要:
Systems and methods are disclosed for compensating for impairments caused by a semiconductor optical amplifier (SOA). One such method comprises receiving an optical signal which has been distorted in the physical domain by an SOA, and propagating the distorted optical signal backward in the electronic domain in a corresponding virtual SOA.
摘要:
Systems and method of compensating for transmission impairment are disclosed. One such method comprises: receiving an optical signal which has been distorted in the physical domain by an optical transmission channel; and propagating the distorted optical signal backward in the electronic domain in a corresponding virtual optical transmission channel.
摘要:
A functional biologically active particle conjugate useful for diagnosis and treating cancer as a bioportal comprises a nanoscale particle having associated therewith an intracellular targeting ligand comprising a PNA, or another nuclease resistant oligonucleotide analog such as MOE-mRNA (2′-methoxyethyl mRNA) or LNA (locked nucleic acid), having a sequence that binds selectively to an uniquely expressed or overexpressed mRNA specific to the cancer or disease state in a living mammal. In one aspect the uniquely overexpressed target specific to the cancer or disease state is the unr mRNA which can be targeted by the antisense sequence PNA50.
摘要:
A functional biologically active particle conjugate useful for diagnosis and treating cancer as a bioportal comprises a nanoscale particle having associated therewith an intracellular targeting ligand comprising a PNA, or another nuclease resistant oligonucleotide analog such as MOE-mRNA (2′-methoxyethyl mRNA) or LNA (locked nucleic acid), having a sequence that binds selectively to an uniquely expressed or overexpressed mRNA specific to the cancer or disease state in a living mammal. In one aspect the uniquely overexpressed target specific to the cancer or disease state is the unr mRNA which can be targeted by the antisense sequence PNA50.